Cargando…
Cetuximab produced from a goat mammary gland expression system is equally efficacious as innovator cetuximab in animal cancer models
There is increasing demand for improved production and purification systems for biosimilar or biobetter humanised monoclonal antibodies and animal production systems offer one such possibile option. Cetuximab, also known as ‘Erbitux’, is a humanised monoclonal antibody widely used in cancer therapy....
Autores principales: | Wang, Qian, Gavin, William, Masiello, Nicholas, Tran, Khanh B., Laible, Götz, Shepherd, Peter R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7528048/ https://www.ncbi.nlm.nih.gov/pubmed/33024714 http://dx.doi.org/10.1016/j.btre.2020.e00533 |
Ejemplares similares
-
Transgenic goats producing an improved version of cetuximab in milk
por: Laible, Götz, et al.
Publicado: (2020) -
Cetuximab-induced skin exanthema: prophylactic and reactive skin therapy are equally effective
por: Wehler, Thomas C., et al.
Publicado: (2013) -
Erratum to: Cetuximab-induced skin exanthema: prophylactic and reactive skin therapy are equally effective
por: Wehler, Thomas C., et al.
Publicado: (2013) -
Cetuximab in the management of colorectal cancer
por: Lenz, Heinz-Josef
Publicado: (2007) -
Phase I Study of Ficlatuzumab and Cetuximab in Cetuximab-Resistant, Recurrent/Metastatic Head and Neck Cancer
por: Bauman, Julie E., et al.
Publicado: (2020)